Canary Capital's Staked INJ ETF Debuts on Nasdaq With 1.10% Expense Ratio
Key Takeaways
- •The Canary Staked INJ ETF, trading under the ticker INJC, started trading on Nasdaq on November 5 with an expense ratio of 1.10%.
- •According to the issuer, the fund is the first US-listed INJ product with staking written directly into its structure.
- •The fund's design allows it to generate staking yield on its INJ holdings in addition to standard spot-price exposure offered by an exchange-traded wrapper.
- •Injective is a layer-1 blockchain oriented toward decentralized finance applications, and INJ serves as the network's native token.
- •The listing reflects a broader shift among US issuers toward altcoin exchange-traded products, several of which incorporate staking into their fund structures.
Canary Capital's staked spot exchange-traded fund holding Injective (INJ) began trading on the Nasdaq on November 5, adding the Injective ecosystem to the growing set of digital assets accessible through US-listed exchange-traded products. The vehicle, the Canary Staked INJ ETF, trades under the ticker INJC and carries an expense ratio of 1.10%. According to the issuer, it is the first US-listed INJ product with staking written directly into its structure.
Staking is the process by which token holders commit assets to support and secure a proof-of-stake blockchain network and, in return, earn rewards. By building staking into the fund's design, the product is structured to generate staking yield on its INJ holdings on top of the standard spot-price exposure offered through an exchange-traded wrapper. In practice, the wrapper format means the exposure and any resulting staking rewards are accessed through shares traded on a regulated national securities exchange, without the holder directly purchasing, storing, and securing the underlying token.
Injective is a layer-1 blockchain geared toward decentralized finance applications, and INJ is the network's native token. INJ holders can stake the asset to participate in network operations while earning rewards, a mechanism that has increasingly appeared in crypto exchange-traded products in the United States. The listing reflects that broader shift, as US issuers have moved beyond the early bitcoin and ether funds toward a widening roster of altcoin products, several of them with staking built into the fund structure.
Canary Capital, a digital asset management firm founded by industry veteran Steven McClurg, has pursued a broad slate of cryptocurrency exchange-traded products in the United States. With INJC, the firm extends that lineup to the Injective ecosystem. The specifics of how staking rewards interact with the fund's 1.10% expense ratio, along with custody and reward-handling mechanics, are set out in the product's regulatory filings, which serve as the primary reference as trading begins.
This article was first published on COINOTAG: https://en.coinotag.com/canary-staked-inj-etf-injc-nasdaq-listing
